EGFR/HER2 Inhibitor AV-412

A second-generation, orally bioavailable dual kinase inhibitor with potential antineoplastic activity. EGFR/HER2 inhibitor AV-412 binds to and inhibits the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2), which may result in the inhibition of tumor growth and angiogenesis, and tumor regression in EGFR/HER2-expressing tumors. This agent may be active against EGFR/HER2-expressing tumor cells that are resistant to first-generation kinase inhibitors. EGFR and HER2 are receptor tyrosine kinases that play major roles in tumor cell proliferation and tumor vascularization. (NCI Thesaurus)

YOU MAY ALSO LIKE

EGFR-TKI Sensitizing Mutation

A molecular genetic abnormality indicating the presence of a sensitizing mutation in the epidermal growth factor receptor-tyrosine kinase inhibitor domain.

EGFR-TKI Resistant Mutation

A molecular genetic abnormality indicating the presence of resistance in the epidermal growth factor receptor-tyrosine kinase inhibitor domain, due to secondary mutations…

EGFR wt Allele

Human EGFR wild-type allele is located within 7p12 and is approximately 188 kb in length. This allele, which encodes epidermal growth factor…

EGFR tyrosine kinase inhibitor

A substance that blocks the activity of a protein called epidermal growth factor receptor (EGFR). EGFR is found on the surface of…

EGFR Protein Variant

A variation in the amino acid sequence for the epidermal growth factor receptor protein.

EGFR Inhibitor PF-00299804

An orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with…